ALA 6.06% 17.5¢ arovella therapeutics limited

Pfizer : Patent Application Titled "*word disallowed by google Sublingual Spray Formulations", page-11

  1. 5,853 Posts.
    lightbulb Created with Sketch. 809
    Not your finest post wasa. What would be more appealing to a big pharma. An i.p. up for challenge or having to foot the legal bill for that legal challenge.

    Given i dont believe suda has any real interested parties or that they have the capabilities to pull off a deal let alone go it alone to develop get approved manufacture and market such a product arguments over the i.p. is largely irrelevant.

    Imho the only hope is if suda flukes enough interest to justify a takeover which sees us getting 5c or so and we all move on. Otherwise it is more of the just over the next hill stuff into the foreseeable future
 
watchlist Created with Sketch. Add ALA (ASX) to my watchlist
(20min delay)
Last
17.5¢
Change
0.010(6.06%)
Mkt cap ! $183.9M
Open High Low Value Volume
17.0¢ 18.5¢ 16.5¢ $460.1K 2.614M

Buyers (Bids)

No. Vol. Price($)
5 255235 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
17.5¢ 189078 5
View Market Depth
Last trade - 16.10pm 23/07/2024 (20 minute delay) ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.